dexamethasone . intragastric pH of preterm infants receiving The effect of intravenous ranitidine on the

Gastric perforation is a catastrophic, albeit uncommon, side effect ofsteroid treatment for premature infants with bronchopulmonary dysplasia (BPD). A reduction of intragastric acidity may protect against peptic ulceration. The effect of different doses of ranitidine, given as intravenous infusions, on intragastric acidity in premature neonates was therefore emined. Ten consecutive, enterally starved, infants receiving dexamethasone (0.6 mg/kg) for BPD were enrolled. Intragastric pH was continuously monitored on the day before steroid treatment and on the four following days, initially without H2 blockade and then using a continuous intravenous infusion of ranitidine at 0-031, 0 0625, and 0-125 mg/kg/hour. An infusion of 0-0625 mg/kg/hour of ranitidine was sufficient to increase and maintain gastric pH above 4; the authors therefore use this infusion during dexamethasone administration as possible prevention of gastric perforation. (Arch Dis Child 1993; 69: 37-39) St James's University Hospital, Leeds, Academic Unit of Paediatrics and Child Health E J Kelly S L Chatfield K G Brownlee P C Ng S J Newell P R F Dear Academic Unit of Surgery

[1]  Y. Yamashiro,et al.  Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia. , 1992, Archives of disease in childhood.

[2]  C. S. Turner,et al.  Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. , 1992, Archives of disease in childhood.

[3]  S. Newell,et al.  Gastro-oesophageal reflux in preterm infants. , 1989, Archives of disease in childhood.

[4]  N. Murray,et al.  Ranitidine in the newborn. , 1988, Archives of disease in childhood.

[5]  C. Infante-Rivard,et al.  Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: prophylaxis trial with cimetidine. , 1986, The Journal of pediatrics.

[6]  J. Sondheimer,et al.  Continuous gastric pH measurement in young and older healthy preterm infants receiving formula and clear liquid feedings. , 1985, Journal of pediatric gastroenterology and nutrition.

[7]  J. Walsh,et al.  Gastric acid secretory function in preterm infants. , 1985, The Journal of pediatrics.

[8]  A. Colón,et al.  The use of cimetidine in the newborn. , 1980, Pediatrics.

[9]  L. Book,et al.  Gastroesophageal reflux causing respiratory distress and apnea in newborn infants. , 1979, The Journal of pediatrics.

[10]  L. Witzel,et al.  Effects of prolonged metiamide medication on the fundic mucosa. A secretory and histomorphometric study in the rat. , 1977, Gastroenterology.

[11]  U. Klotz,et al.  Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine. , 1991, Digestion.

[12]  C. Wilder-Smith,et al.  Loss of acid suppression during dosing with H2-receptor antagonists. , 1990, Alimentary pharmacology & therapeutics.

[13]  J. Primrose,et al.  The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin. , 1990, Alimentary Pharmacology and Therapeutics.

[14]  J. Wallace,et al.  Is dietary epidermal growth factor absorbed by premature human infants? , 1989, Biology of the neonate.